Onderneming biOasis Technologies Inc Toronto S.E.
Aandelen
BTI
CA09064N1033
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Diagnosis and Treatment of Neurological Diseases and Disorders
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07% |
Verkoop per regio
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 21-09-17 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 01-07-21 |
Mei Mei Tian
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-12 |
Graeme Dick
IRC | Investor Relations Contact | - | 01-11-11 |
Christopher Lowe
SEC | Corporate Secretary | 56 | 03-10-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Hemeon
BRD | Director/Board Member | 59 | - |
David Wurzer
BRD | Director/Board Member | 65 | 27-07-18 |
Deborah Rathjen
CEO | Chief Executive Officer | - | 21-09-17 |
Director/Board Member | 63 | 01-06-18 | |
John E. Curran
BRD | Director/Board Member | - | 27-07-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 79 414 015 | 77 784 778 ( 97,95 %) | 0 | 97,95 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+24,73% | 12,17 mld. | |
+28,31% | 12,16 mld. | |
-6,26% | 11,42 mld. |